TY - JOUR
T1 - Three Dimensional Visualisation of Endovascular Guidewires and Catheters Based on Laser Light instead of Fluoroscopy with Fiber Optic RealShape Technology
T2 - Preclinical Results
AU - Jansen, Marloes
AU - Khandige, Anuradha
AU - Kobeiter, Hicham
AU - Vonken, Evert Jan
AU - Hazenberg, Constantijn
AU - van Herwaarden, Joost
N1 - Funding Information:
This work was supported by Philips Medical Systems Netherlands B.V.
Funding Information:
Philips Medical Systems Netherlands B.V provided a research grant according to fair market value to the Division of Surgical Specialties of the University Medical Center Utrecht to support this study. Dr van Herwaarden, Dr Hazenberg, and Ms Jansen are part of this division. Professor Kobeiter is a consultant for Philips Medical Systems. Ms Khandige is an employee of Philips Medical Systems. The Philips FORS team had a role in the study design, technical support, and data collection. The views expressed in this article are those of the authors and do not necessarily reflect those of Philips Medical Systems.
Publisher Copyright:
© 2020 European Society for Vascular Surgery
PY - 2020/7
Y1 - 2020/7
N2 - Objective: Fiber Optic RealShape (FORS) is a new technology platform that enables real time three dimensional (3D) visualisation of endovascular guidewires and catheters, based on the concepts of fibre optic technology instead of fluoroscopy. Anatomical context is provided by means of co-registered prior anatomical imaging, such as digital subtraction angiography or computed tomography. This preclinical study assesses the safety and feasibility of FORS technology. Methods: Six physicians performed endovascular tasks in a phantom model and a porcine model using FORS enabled floppy guidewires, Cobra-2 catheters and Berenstein catheters. Each physician performed a set of predefined tasks in both models, including setup of the FORS system, device registration, and 12 aortic and peripheral target vessel cannulation tasks. The evaluation of the FORS system was based on (i) target vessel cannulation success; (ii) safety assessment; (iii) the accuracy of the FORS based device visualisation; and (iv) user experience. Results: Successful cannulation was achieved in 72 of the 72 tasks (100%) in the phantom model and in 70 of the 72 tasks (97%) in the porcine model. No safety issues were reported. The FORS based device visualisation had a median offset at the tip of 2.2 mm (interquartile range 1.2–3.8 mm). The users judged the FORS based device visualisation to be superior to conventional fluoroscopic imaging, while not affecting the mechanical properties (torquability, pushability) of the FORS enabled guidewire and catheters. Conclusion: The combined outcomes of high cannulation success, positive user experience, adequate accuracy, and absence of safety issues demonstrate the safety and feasibility of the FORS system in a preclinical environment. FORS technology has great potential to improve device visualisation in endovascular interventions.
AB - Objective: Fiber Optic RealShape (FORS) is a new technology platform that enables real time three dimensional (3D) visualisation of endovascular guidewires and catheters, based on the concepts of fibre optic technology instead of fluoroscopy. Anatomical context is provided by means of co-registered prior anatomical imaging, such as digital subtraction angiography or computed tomography. This preclinical study assesses the safety and feasibility of FORS technology. Methods: Six physicians performed endovascular tasks in a phantom model and a porcine model using FORS enabled floppy guidewires, Cobra-2 catheters and Berenstein catheters. Each physician performed a set of predefined tasks in both models, including setup of the FORS system, device registration, and 12 aortic and peripheral target vessel cannulation tasks. The evaluation of the FORS system was based on (i) target vessel cannulation success; (ii) safety assessment; (iii) the accuracy of the FORS based device visualisation; and (iv) user experience. Results: Successful cannulation was achieved in 72 of the 72 tasks (100%) in the phantom model and in 70 of the 72 tasks (97%) in the porcine model. No safety issues were reported. The FORS based device visualisation had a median offset at the tip of 2.2 mm (interquartile range 1.2–3.8 mm). The users judged the FORS based device visualisation to be superior to conventional fluoroscopic imaging, while not affecting the mechanical properties (torquability, pushability) of the FORS enabled guidewire and catheters. Conclusion: The combined outcomes of high cannulation success, positive user experience, adequate accuracy, and absence of safety issues demonstrate the safety and feasibility of the FORS system in a preclinical environment. FORS technology has great potential to improve device visualisation in endovascular interventions.
KW - Endovascular navigation
KW - Endovascular surgery
KW - Fibre optic technology
KW - Imaging
KW - Multimodality imaging
KW - Three dimensional
KW - Translational studies
KW - Blood Vessels/diagnostic imaging
KW - Humans
KW - Animals
KW - Swine
KW - Catheterization, Peripheral/instrumentation
KW - Vascular Access Devices
KW - Endovascular Procedures/instrumentation
KW - Female
KW - Fiber Optic Technology/methods
KW - Imaging, Three-Dimensional/instrumentation
UR - http://www.scopus.com/inward/record.url?scp=85083301695&partnerID=8YFLogxK
U2 - 10.1016/j.ejvs.2020.02.035
DO - 10.1016/j.ejvs.2020.02.035
M3 - Article
C2 - 32312666
AN - SCOPUS:85083301695
SN - 1078-5884
VL - 60
SP - 135
EP - 143
JO - European Journal of Vascular and Endovascular Surgery
JF - European Journal of Vascular and Endovascular Surgery
IS - 1
ER -